"The U.S. Food and Drug Administration today announced it is requiring the removal of certain restrictions on prescribing and use of the diabetes drug Avandia (rosiglitazone) to reflect new information regarding the cardiovascular risk of the medi"...
(Generic versions may still be available.)
- Clinician Information:
Velosulin Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Velosulin (insulin human) is a form of insulin used to treat diabetes mellitus. The brand name of this medication is discontinued, but generic versions may be available. Side effects are uncommon but may include allergic reaction, or injection site reactions such as redness, swelling, itching, and fatty lumps.
A physician will determine the dose of Velosulin. Velosulin may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Velosulin. Consult your doctor before breastfeeding. Insulin needs may change during pregnancy or while breastfeeding; consult your doctor.
Our Velosulin (insulin human) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Velosulin FDA Prescribing Information: Side Effects
Insulin allergy occurs very rarely, but when it does, it may cause a serious reaction including a general skin rash over the body, shortness of breath, fast pulse, sweating and a drop in blood pressure. If any of these symptoms develop you should seek emergency medical care. The formation of fatty lumps at the infusion site or injection site is usually a sign of frequent needle insertion at the same site. Remember to choose new infusion sites or injection sites at which to insert each new needle and consult with your physician or diabetes educator if you develop these fatty lumps at the infusion site. The skin at the infusion site or injection site may also become red, swollen and itchy. This is a local reaction. It may occur if needle insertion is not properly made at the infusion site or injection site, or as a result of skin sensitivity to the cleansing solutions or if the patient is allergic to insulin. If you have a local reaction, consult with your physician or diabetes educator. Patients with severe systemic allergic reactions to insulin (i.e. generalized urticaria, angioedema, anaphylaxis) should be skin tested with each new preparation to be used prior to initiation of therapy with that preparation.
Read the entire FDA prescribing information for Velosulin (Insulin Human) »
Additional Velosulin Information
Report Problems to the Food and Drug Administration
Find tips and advances in treatment.